130 related articles for article (PubMed ID: 22315118)
21. [Therapeutic management of extensive bronchiolo-alveolar adenocarcinoma: chemotherapy or inhibitors of epidermal growth factor receptor tyrosine kinase?].
Cadranel J; Wislez M; Gounant V; Lavolé A; Antoine M; Milleron B
Rev Pneumol Clin; 2007 Jun; 63(3):147-54. PubMed ID: 17675938
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy of gefitinib (Iressa) in the treatment of an inoperable bronchioloalveolar cell carcinoma].
Bayle S; Descourt R; Gouva S; Daniel C; Robinet G
Rev Mal Respir; 2004 Feb; 21(1):153-7. PubMed ID: 15260051
[TBL] [Abstract][Full Text] [Related]
23. Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126.
West HL; Franklin WA; McCoy J; Gumerlock PH; Vance R; Lau DH; Chansky K; Crowley JJ; Gandara DR
J Clin Oncol; 2006 Apr; 24(12):1807-13. PubMed ID: 16622257
[TBL] [Abstract][Full Text] [Related]
24. Bronchioloalveolar carcinoma with bronchorrhoea treated with erythromycin.
Suga T; Sugiyama Y; Fujii T; Kitamura S
Eur Respir J; 1994 Dec; 7(12):2249-51. PubMed ID: 7713212
[TBL] [Abstract][Full Text] [Related]
25. Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition.
Gandara DR; West H; Chansky K; Davies AM; Lau DH; Crowley J; Gumerlock PH; Hirsch FR; Franklin WA
Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4205s-4209s. PubMed ID: 15217959
[TBL] [Abstract][Full Text] [Related]
26. Response to pemetrexed chemotherapy in lung adenocarcinoma-bronchioloalveolar carcinoma insensitive to erlotinib.
Manson GV; Ma PC
Clin Lung Cancer; 2010 Jan; 11(1):57-60. PubMed ID: 20085869
[TBL] [Abstract][Full Text] [Related]
27. Bronchioloalveolar carcinoma accompanied by severe bronchorrhea.
Hidaka N; Nagao K
Chest; 1996 Jul; 110(1):281-2. PubMed ID: 8681643
[TBL] [Abstract][Full Text] [Related]
28. Bronchorrhea in bronchioloalveolar carcinoma.
Psathakis K; Bostantzoglou K; Sambaziotis D; Tsintiris K
Respiration; 2011; 82(1):54-5. PubMed ID: 21555870
[No Abstract] [Full Text] [Related]
29. Systemic therapy of bronchioloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinoma.
Kris MG; Giaccone G; Davies A; Fukuoka M; Garfield DH; Jassem J; Quoix EA; Sandler AB; Scagliotti GV; Van Meerbeeck JP; West H
J Thorac Oncol; 2006 Nov; 1(9 Suppl):S32-6. PubMed ID: 17409999
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary pleomorphic carcinoma: a clinicopathological study including EGFR mutation analysis.
Kaira K; Horie Y; Ayabe E; Murakami H; Takahashi T; Tsuya A; Nakamura Y; Naito T; Endo M; Kondo H; Nakajima T; Yamamoto N
J Thorac Oncol; 2010 Apr; 5(4):460-5. PubMed ID: 20107421
[TBL] [Abstract][Full Text] [Related]
31. Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: a case report.
Dziadziuszko R; Siemiatkowska A; Limon J; Rzyman W; Jassem J; Bunn PA; Varella-Garcia M; Hirsch FR
J Thorac Oncol; 2007 Jan; 2(1):91-2. PubMed ID: 17410018
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of persistent bronchorrhea by gefitinib in a case with Recurrent Bronchioloalveolar Carcinoma: a case report.
Takao M; Inoue K; Watanabe F; Onoda K; Shimono T; Shimpo H; Yada I
World J Surg Oncol; 2003 Jul; 1(1):8. PubMed ID: 12917017
[TBL] [Abstract][Full Text] [Related]
33. Synchronous multiple primary lung cancers with different response to gefitinib.
Ryoo BY; Na II; Yang SH; Koh JS; Kim CH; Lee JC
Lung Cancer; 2006 Aug; 53(2):245-8. PubMed ID: 16787685
[TBL] [Abstract][Full Text] [Related]
34. Gefitinib as first-line, compassionate use therapy in patients with advanced non-small-cell lung cancer.
Argiris A; Mittal N
Lung Cancer; 2004 Mar; 43(3):317-22. PubMed ID: 15165090
[TBL] [Abstract][Full Text] [Related]
35. A phase II trial of erlotinib as front-line treatment in clinically selected patients with non-small-cell lung cancer.
Pallis AG; Voutsina A; Kentepozidis N; Giassas S; Papakotoulas P; Agelaki S; Tryfonidis K; Kotsakis A; Vamvakas L; Vardakis N; Georgoulias V
Clin Lung Cancer; 2012 Mar; 13(2):129-35. PubMed ID: 22000696
[TBL] [Abstract][Full Text] [Related]
36. Bronchorrhea revealing cervix adenocarcinoma metastastic to the lung.
Epaulard O; Moro D; Langin T; Devouassoux G; Brambilla C
Lung Cancer; 2001; 31(2-3):331-4. PubMed ID: 11165415
[TBL] [Abstract][Full Text] [Related]
37. Major and prolonged response to pemetrexed in two cases of lung adenocarcinoma with bronchioloalveolar carcinoma features.
Duruisseaux M; Cadranel J; Biron E; Pérol M; Guérin JC; Arpin D
Lung Cancer; 2009 Sep; 65(3):385-7. PubMed ID: 19346028
[TBL] [Abstract][Full Text] [Related]
38. Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings.
Lee KS; Kim Y; Han J; Ko EJ; Park CK; Primack SL
Radiographics; 1997; 17(6):1345-57. PubMed ID: 9397450
[TBL] [Abstract][Full Text] [Related]
39. Erlotinib after failure of gefitinib in patients with advanced non-small cell lung cancer previously responding to gefitinib.
Vasile E; Tibaldi C; Chella A; Falcone A
J Thorac Oncol; 2008 Aug; 3(8):912-4. PubMed ID: 18670311
[TBL] [Abstract][Full Text] [Related]
40. Good response to gefitinib for lung adenocarcinoma with hyperamylasemia: a case report.
Ko HW; Tsai YH; Yu CT; Huang CY; Chen CH
Chang Gung Med J; 2008; 31(6):606-11. PubMed ID: 19241901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
